COVID-19

Novavax
Biotech

FDA puts Novavax's phase 3 plan on hold for pair of vaccines

A phase 2 trial wrapped up in July 2023, with the “spontaneous” report of a patient developing motor neuropathy received last month.
James Waldron Oct 16, 2024 9:10am
3D rendering of SARS-CoV-2 virus particles

COVID antibodies shut down variants, earn $35M BARDA bucks

Oct 9, 2024 2:00pm
Home COVID swab test

FDA clears at-home COVID/flu combo test with eye on fall season

Oct 8, 2024 11:05am
Close-up of female doctor with a nasal spray

Nasal spray protects mice from deadly flu

Oct 2, 2024 8:54am
COVID-19 danger coronavirus pandemic quarantine

Atea's COVID antiviral fails to halt hospitalizations in phase 3

Sep 13, 2024 10:10am
flu virus b cells influenza

Pfizer, BioNTech combo mRNA shot latest to lose to flu strain B

Aug 16, 2024 8:25am
More News

'Mini-lungs' reveal COVID's activity and the lung's immunity

Aug 7, 2024 11:32am

Drug prevents COVID symptoms in mice by protecting mitochondria

Jul 16, 2024 4:00am

Infinity Pharma cancer drug stops COVID, MRSA damage in mice

Jul 9, 2024 7:00am

'Active' vaccine adjuvant boosts COVID, flu antibodies in mice

Jul 9, 2024 4:00am